| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| I1IWD9 | tRNA-dihydrouridine synthase; EC 1.-.-.-; | BRADI5G03740; | NULL | 348 | bromus |
| I1IMA5 | Uncharacterized protein; | BRADI4G21265; | XP_003576119.1; | 192 | bromus |
| I1HLN5 | Uncharacterized protein; | BRADI2G35167; | NULL | 745 | bromus |
| I1GS37 | UMP-CMP kinase; EC 2.7.4.14; Deoxycytidylate kinase; Uridine monophosphate/cytidine monophosphate kinase; | BRADI1G20640; | XP_003562640.1; | 213 | bromus |
| I1HCH6 | Uncharacterized protein; | BRADI2G04577; | NULL | 1493 | bromus |
| I1GZS8 | Uncharacterized protein; | BRADI1G45833; | XP_003564094.1; | 1291 | bromus |
| I1HDF0 | Uncharacterized protein; | BRADI2G07357; | NULL | 356 | bromus |
| I1IZY5 | Uncharacterized protein; | BRADI5G16497; | XP_003580193.1; | 271 | bromus |
| I1I4F4 | Inosine triphosphate pyrophosphatase; ITPase; Inosine triphosphatase; EC 3.6.1.19; Non-canonical purine NTP pyrophosphatase; Non-standard purine NTP pyrophosphatase; Nucleoside-triphosphate diphosphatase; Nucleoside-triphosphate pyrophosphatase; | BRADI3G27950; | XP_003574005.1; | 200 | bromus |
| I1IDV1 | Uncharacterized protein; | BRADI3G55220; | XP_003570386.1; | 381 | bromus |
| I1HQS2 | Uncharacterized protein; | BRADI2G47690; | XP_003567038.1; | 221 | bromus |
| I1GRN9 | Uncharacterized protein; | BRADI1G19360; | NULL | 302 | bromus |
| I1GR40 | Uncharacterized protein; | BRADI1G17630; | XP_003562446.1; | 485 | bromus |
| I1GKP2 | Uncharacterized protein; | BRADI1G01130; | XP_003559114.1; | 525 | bromus |
| I1HWT8 | Uncharacterized protein; | BRADI3G02760; | NULL | 173 | bromus |
| I1GUI4 | Uncharacterized protein; | BRADI1G27980; | XP_003563128.1; | 129 | bromus |
| I1I796 | Uncharacterized protein; | BRADI3G36510; | XP_003574512.1; | 889 | bromus |
| A8Y7W7 | Putative wuschel homeobox protein; Fragment; | wox2; | NULL | 41 | bromus |
| A8Y7X0 | Putative wuschel homeobox protein; Fragment; | wox5; | NULL | 41 | bromus |
| A8Y7X3 | Putative wuschel homeobox protein; Fragment; | wus; | NULL | 42 | bromus |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |